Blood Cancer Clinical Trials
2 recruiting trials for Blood Cancer. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Blood Cancer clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Massachusetts General Hospital (1), Hospital Universitari Vall d'Hebron Research Institute (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Palliative Care (behavioral, 1 trial), followed by Usual Care, Collection of clinical and laboratory data from EHR..
Track Blood Cancer trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
The goal of this study is to determine whether a palliative care intervention (PEACE) can improve the quality of life and experiences of participants with Lymphoma, Leukemia, or...
European Rare Blood Disorders Platform (ENROL)
ENROL, the European Rare Blood Disorders Platform has been conceived in the core of ERN-EuroBloodNet as an umbrella for both new and already existing registries on Rare...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Blood Cancer, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Blood Cancer, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Blood Cancer, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.